Department of Collective Health, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.
Center for Public Health Research, San Francisco Department of Public Health, San Francisco, California, USA.
LGBT Health. 2021 Feb-Mar;8(2):162-166. doi: 10.1089/lgbt.2020.0059. Epub 2021 Jan 13.
The purpose of this study was to determine the prevalence and correlates of nonprescription hormone use among Brazilian trans women. This study is a cross-sectional survey of trans women in São Paulo, Brazil, recruited by respondent-driven sampling in 2017-2019. Of 790 trans women, 36.8% were taking nonprescribed hormones. Nonprescribed hormone use was higher with younger age, lower education, homelessness, and using estrogen plus progesterone. Lower use was associated with accessing health care and having trans-specific health needs met. Marginalized Brazilian trans women exhibit high use of nonprescription hormones, which may have health consequences and requires further examination and research.
本研究旨在确定巴西跨性别女性中非处方激素使用的流行率和相关因素。本研究是 2017-2019 年在巴西圣保罗通过应答者驱动抽样对跨性别女性进行的横断面调查。在 790 名跨性别女性中，36.8%正在服用非处方激素。非处方激素的使用与年龄较小、教育程度较低、无家可归以及同时使用雌激素和孕激素有关。使用率较低与获得医疗保健和满足跨性别特定健康需求有关。边缘化的巴西跨性别女性大量使用非处方激素，这可能会带来健康后果，需要进一步研究和关注。
